Talon Therapeutics is a biopharmaceutical company committed to identifying and seizing medical opportunities, expertly leading product candidates through clinical development and passing on value to patients, patient care providers, shareholders, corporate partners and employees. Marqibo, the company’s lead asset, as well as Talon Therapeutics’ other pipeline opportunities, has the potential to improve delivery and therapeutic benefits of well-characterized, proven chemotherapies – enabling high potency doses without increasing toxicity. For more information, visit the company’s Web site at www.talontx.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: